The Influence of Study Design on the Results of Pharmacoepidemiologic Studies of Diabetes Risk With Antipsychotic Therapy

Author： Gianfrancesco Frank   Wang Ruey-Hua   Nasrallah Henry  

Publisher： Informa Healthcare

ISSN： 1040-1237

Source： Annals of Clinical Psychiatry (after Jan 1, 2004), Vol.18, Iss.1, 2006-01, pp. : 9-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular and cerebrovascular risk factors and events associated with second‐generation antipsychotic compared to antidepressant use in a non‐elderly adult sample: results from a claims‐based inception cohort study

By  

World Psychiatry, Vol. 14, Iss. 1, 2015-02 ,pp. : 56-63

John Wiley & Sons Inc

Access to resources Recommend Favorite

“Real world” study of antipsychotic effectiveness for chronic inpatients with schizophrenia in a state psychiatric hospital: Preliminary results and commentary

By Comaty Joseph   Advokat Claire  

Journal of Mental Health, Vol. 15, Iss. 1, 2006-02 ,pp. : 57-62

Informa Healthcare

Access to resources Recommend Favorite

Obesity as a risk factor for antipsychotic noncompliance

By Weiden P.J.   Mackell J.A.   McDonnell D.D.  

Schizophrenia Research, Vol. 66, Iss. 1, 2004-01 ,pp. : 51-57

Elsevier

Access to resources Recommend Favorite

Neuroleptic Malignant Syndrome During Multiple Antipsychotic Therapy

By McDermott Margaret  

Community Mental Health Journal, Vol. 49, Iss. 1, 2013-02 ,pp. : 45-46

Springer Publishing Company

Access to resources Recommend Favorite

Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia

By Kuo Chian-Jue   Yang Shu-Yu   Liao Ya-Tang   Chen Wei J.   Lee Wen-Chung   Shau Wen-Yi   Chang Yao-Tung   Tsai Shang-Ying   Chen Chiao-Chicy  

Schizophrenia Bulletin, Vol. 39, Iss. 3, 2013-05 ,pp. : 648-657

Oxford University Press

Access to resources Recommend Favorite